KSI vs. VHI, CARE, RHT, ADK, DOC, EKG, ZMD, CNNA, CARE.TO, and UDOC
Should you be buying kneat.com stock or one of its competitors? The main competitors of kneat.com include Vitalhub (VHI), Dialogue Health Technologies (CARE), Reliq Health Technologies (RHT), DIAGNOS (ADK), CloudMD Software & Services (DOC), CardioComm Solutions (EKG), ZoomMed (ZMD), Cann American (CNNA), Dialogue Health Technologies (CARE.TO), and Unidoc Health (UDOC). These companies are all part of the "health information services" industry.
kneat.com vs.
Vitalhub (TSE:VHI) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk.
Vitalhub has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, kneat.com has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.
Vitalhub has a net margin of 8.14% compared to kneat.com's net margin of -31.19%. Vitalhub's return on equity of 4.73% beat kneat.com's return on equity.
Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.
In the previous week, Vitalhub had 1 more articles in the media than kneat.com. MarketBeat recorded 2 mentions for Vitalhub and 1 mentions for kneat.com. Vitalhub's average media sentiment score of 0.27 beat kneat.com's score of 0.00 indicating that Vitalhub is being referred to more favorably in the media.
Vitalhub received 5 more outperform votes than kneat.com when rated by MarketBeat users. However, 100.00% of users gave kneat.com an outperform vote while only 69.23% of users gave Vitalhub an outperform vote.
Vitalhub presently has a consensus price target of C$9.44, indicating a potential downside of 15.59%. kneat.com has a consensus price target of C$6.00, indicating a potential downside of 0.17%. Given kneat.com's stronger consensus rating and higher possible upside, analysts clearly believe kneat.com is more favorable than Vitalhub.
32.4% of Vitalhub shares are held by institutional investors. Comparatively, 13.0% of kneat.com shares are held by institutional investors. 18.6% of Vitalhub shares are held by company insiders. Comparatively, 26.0% of kneat.com shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
Vitalhub beats kneat.com on 13 of the 19 factors compared between the two stocks.
Get kneat.com News Delivered to You Automatically
Sign up to receive the latest news and ratings for KSI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
kneat.com Competitors List
Related Companies and Tools
This page (TSE:KSI) was last updated on 12/26/2024 by MarketBeat.com Staff
